StreetAccount Sector Summary - Healthcare Pre-Market
StreetAccount Sector Summary - Healthcare Post-Market
StreetAccount Summary - US Pre-market trading update
StreetAccount Summary - US Pre-market trading
Fresenius Medical Care further accelerates organic revenue development and achieves an inflection in earnings growth, delivering 28% operating income growth in the third quarter of 2025
Basic resources, telecoms and retail the biggest decliners; defensives like real estate and utilities outperform:
StreetAccount Summary - Trading higher/lower: EU mid-morning
StreetAccount Summary - European pre-market trading update
Quick Take - Fresenius Medical Care set for a positive open after Q3 earnings beat, strong organic growth and confirmed FY guidance (€45.67, 0.00)
Powered by FactSet Research Systems Inc.